These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 476673)

  • 1. Enhancement of antitumor activity of 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine and Baker's antifol (triazinate) with carboxypeptidase G1.
    Kalghatgi KK; Moroson BA; Horváth C; Bertino JR
    Cancer Res; 1979 Sep; 39(9):3441-5. PubMed ID: 476673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of DNA synthesis in normal and malignant human cells by triazinate (Baker's antifol) and methotrexate.
    Skeel RT; Sawicki WL; Cashmore AR; Bertino JR
    Cancer Res; 1976 Oct; 36(10):3659-64. PubMed ID: 953990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination antifol therapy: observations on the development of resistant L1210 leukemic cells in vivo.
    Browman GP; Lazarus H
    Cancer Treat Rep; 1980; 64(2-3):231-6. PubMed ID: 7407755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of a new triazine antifolate in mice, rats, dogs, and monkeys.
    Cashmore AR; Skeel RT; Makulu DR; Gralla EJ; Bertino JR
    Cancer Res; 1975 Jan; 35(1):17-22. PubMed ID: 803254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of Baker's antifol (triazinate, TZT, NSC-139,105) in advanced squamous cell carcinoma of cervix.
    Arseneau JC; Bundy B; Dolan T; Homesley H; DiSaia PJ
    Am J Clin Oncol; 1982 Feb; 5(1):61-4. PubMed ID: 6211087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the antitumor activity and toxicity of 2,4-diamino-5-(1-adamantyl)-6-methylpyrimidine and 2,4-diamino-5-(1-adamantyl)-6-ethylpyrimidine.
    Zakrzewski SF; Dave C; Rosen F
    J Natl Cancer Inst; 1978 May; 60(5):1029-33. PubMed ID: 580441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystallographic studies of the antineoplastic antifolate 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (DDMP) ethanesulfonate salt.
    Cody V
    Cancer Biochem Biophys; 1983; 6(3):173-7. PubMed ID: 6850552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New dose-time relationships of folate antagonists to sustain inhibition of human lymphoblasts and leukemic cells in vitro.
    Sedwick WD; Kutler M; Frazer T; Brown OE; Laszlo J
    Cancer Res; 1979 Sep; 39(9):3612-8. PubMed ID: 314333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of dihydrofolate reductase, thymidylate synthetase, and thymidine kinase in cultured mammalian cells after exposure to folate antagonists.
    Chello PL; McQueen CA; DeAngelis LM; Bertino JR
    Cancer Res; 1976 Jul; 36(7 PT 1):2442-9. PubMed ID: 1277151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human plasma and amino acids as moderators of uptake and metabolic consequences of antifolates in WIL-2 and human leukemia cells.
    Fyfe MJ; Sedwick WD; Brown OE; Laszlo J
    J Natl Cancer Inst; 1981 Mar; 66(3):445-51. PubMed ID: 6937701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental chemotherapy with 5-arylpyrimidine antifolates: Further studies on toxicity and the responsiveness of ascitic, solid, and intracranial sarcoma 180 to DDMP and DDMP with citrovorum factor.
    Sirotnak FM; Moccio DM; Dorick DM
    Cancer Treat Rep; 1977 Oct; 61(7):1325-32. PubMed ID: 303937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of a folate-cleaving enzyme, carboxypeptidase G 1 .
    Chabner BA; Chello PL; Bertino JR
    Cancer Res; 1972 Oct; 32(10):2114-9. PubMed ID: 5080761
    [No Abstract]   [Full Text] [Related]  

  • 13. Potentiation by clofibrate of in-vivo tumor inhibition by hydrazine sulfate and cytotoxic agents, in Walker 256 carcinosarcoma.
    Gold J
    Cancer Biochem Biophys; 1978; 3(1):41-5. PubMed ID: 552898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic effects of folate antagonists against methotrexate-resistant human leukemic lymphoblast CCRF-CEM cell lines.
    Mini E; Moroson BA; Franco CT; Bertino JR
    Cancer Res; 1985 Jan; 45(1):325-30. PubMed ID: 3855284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baker's antifol in combination with 5-fluorouracil and methyl-CCNU in the treatment of metastatic colorectal cancer: a Southwest Oncology Group Study (Protocol 7764).
    Shaw MT; Bonnet JD; Wilson H; Heilbrun LK
    Cancer Treat Rep; 1980; 64(2-3):247-50. PubMed ID: 7407758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of citrovorum factor and carboxypeptidase G1 on cerebrospinal fluid-methotrexate pharmacokinetics.
    Abelson HT; Ensminger W; Rosowsky A; Uren J
    Cancer Treat Rep; 1978 Oct; 62(10):1549-52. PubMed ID: 309355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approaches to chemotherapy with folate antagonists: use of leucovorin "rescue" and enzymic folate depletion.
    Bertino JR; Levitt M; McCullough JL; Chabner B
    Ann N Y Acad Sci; 1971 Nov; 186():486-95. PubMed ID: 4943812
    [No Abstract]   [Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer: A Gastrointestinal Tumor Study Group Report.
    Bruckner HW; Lokich JJ; Stablein DM
    Cancer Treat Rep; 1982 Sep; 66(9):1713-7. PubMed ID: 7116348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical chemotherapy of intradermal Walker 256 carcinosarcoma with diaziquone and doxorubicin in the rat.
    Moore DJ; Powis G; Richardson RL; Pittelkow MR
    Cancer Res; 1985 Nov; 45(11 Pt 1):5466-72. PubMed ID: 4053022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.